SLC30A3 — Solute Carrier Family 30 Member 3 (ZnT3)

📖 Wiki Page

gene3641 wordssynced 2026-04-02

SLC30A3 — Solute Carrier Family 30 Member 3 (ZnT3)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SLC30A3 — ZnT3 (Zinc Transporter 3)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>SLC30A3</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Solute Carrier Family 30 Member 3</td>
</tr>
<tr>
<td class="label">Alias</td>
<td>ZnT3</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>2p23.3</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td>[22798](https://www.ncbi.nlm.nih.gov/gene/22798)</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>[613315](https://www.omim.org/entry/613315)</td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td>[ENSG00000130052](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000130052)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[Q9H3M0](https://www.uniprot.org/uniprot/Q9H3M0)</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>388 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~44 kDa</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Cation diffusion facilitator, zinc transporter</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Hippocampus, Cortex, Amygdala, Cerebellum</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

SLC30A3 — Solute Carrier Family 30 Member 3 (ZnT3)

...

SLC30A3 — Solute Carrier Family 30 Member 3 (ZnT3)

Pathway / Mechanism Diagram

Mermaid diagram (expand to render)

Overview

SLC30A3 (Solute Carrier Family 30 Member 3), also known as ZnT3 (Zinc Transporter 3), is a member of the SLC30 family of zinc transporters. ZnT3 is essential for transporting zinc into synaptic vesicles, making it a critical regulator of synaptic zinc signaling and overall brain zinc homeostasis. [@ncbi_gene] The protein is highly expressed in brain regions associated with learning and memory, particularly the hippocampus and cerebral cortex, where it plays pivotal roles in synaptic plasticity, cognitive function, and ultimately in the pathogenesis of neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease). [@sensi2018]

Zinc is the second most abundant trace metal in the brain after iron, and serves as both a structural cofactor and a signaling molecule. At synapses, ZnT3 packages zinc into synaptic vesicles, where it is released during neuronal activity. This synaptically released zinc acts as a potent neuromodulator, influencing synaptic transmission, plasticity, and ultimately cognitive processes. The importance of ZnT3 is underscored by observations that genetic deletion of ZnT3 in mice results in dramatic deficits in learning and memory. [@hyde2011]

This page reviews ZnT3's biological function, its critical role in synaptic zinc signaling, the relationship between zinc dyshomeostasis and neurodegenerative disease, and therapeutic implications.

Normal Biological Function

Zinc Biology in the Brain

Zinc is essential for normal brain function, participating in numerous enzymatic reactions, structural roles in proteins, and as a signaling molecule. Brain zinc homeostasis is tightly regulated by a sophisticated network of zinc transporters (SLC30A/ZnT and SLC39A/ZIP families) that control zinc uptake, efflux, and intracellular compartmentalization. [@frederickson2003]

The ZnT family (SLC30) reduces cytosolic zinc by transporting it into intracellular compartments or extracellular spaces, while the ZIP family (SLC39) increases cytosolic zinc by transporting it from extracellular sources or intracellular stores.

Types of Zinc in the Brain

Brain zinc exists in distinct pools:

| Pool | Location | Function |
|------|----------|----------|
| Bound zinc | Metalloproteins, enzymes | Structural cofactor |
| Vesicular zinc | Synaptic vesicles | Neurotransmission |
| Free zinc | Cytosol, extracellular | Signaling |
| Mitochondrial zinc | Mitochondria | Metabolic regulation |

ZnT3 Structure and Function

ZnT3 is a 388-amino acid protein belonging to the cation diffusion facilitator (CDF) family. Like other ZnT proteins, ZnT3 has six transmembrane domains and functions as a dimer. [@uniprot] The protein localizes to synaptic vesicles in presynaptic terminals, where it actively transports zinc from the cytoplasm into the vesicular lumen.

Transport Mechanism

ZnT3 mediates zinc transport through an electrogenic mechanism:

Zinc binding: Cytosolic zinc binds to the transporter's regulatory site

Conformational change: Zinc binding triggers a conformational change

Vesicular uptake: Zinc is transported into the synaptic vesicle lumen

Vesicle release: During exocytosis, zinc is released into the synaptic cleft

The driving force for zinc transport is the proton gradient established by the vacuolar-type H+-ATPase (vATPase), which pumps protons into synaptic vesicles. [@pan2011]

Synaptic Zinc Signaling

Synaptic zinc release represents a unique form of neuromodulation. Unlike classical neurotransmitters, zinc is not packaged in synaptic vesicles by the classic vesicular release machinery but is instead accumulated by ZnT3 and released in a vesicle-dependent manner. [@smart2011]

Release Mechanisms

Zinc release from synaptic vesicles occurs through:

Activity-dependent exocytosis: Vesicular release during neuronal firing
Reverse transport: ZnT3 can operate in reverse under certain conditions
Channel-mediated release: Through zinc-permeable ion channels

Postsynaptic Targets

Once released, synaptic zinc modulates several postsynaptic targets:

| Target | Effect | Receptor/Channel |
|--------|--------|------------------|
| NMDA receptors | Inhibition | NR2A/B subunits |
| AMPA receptors | Modulation | GluA1-4 |
| GABA receptors | Potentiation | GABA-A |
| Voltage-gated Ca channels | Modulation | L-type, N-type |
| mGluR receptors | Modulation | Group I mGluRs |

These actions make zinc a versatile neuromodulator that can fine-tune synaptic transmission and plasticity. [@mccord2011]

Role in Synaptic Plasticity

Synaptic plasticity, the activity-dependent modification of synaptic strength, is the cellular basis of learning and memory. ZnT3 and synaptic zinc play crucial roles in these processes.

Long-Term Potentiation (LTP)

LTP is a persistent strengthening of synapses observed after high-frequency stimulation. ZnT3 contributes to LTP through several mechanisms:

NMDA receptor modulation: Zinc inhibits NMDA receptors at resting potentials, but this inhibition is relieved during high-frequency stimulation, allowing calcium influx and LTP induction

Signal transduction: Zinc activates intracellular signaling pathways including MAPK/ERK and CaMKII

AMPA receptor trafficking: Zinc modulates the trafficking of AMPA receptors to the postsynaptic membrane

Studies in ZnT3 knockout mice show impaired LTP in hippocampal CA1 neurons, supporting a critical role for synaptic zinc in plasticity. [@moyer2011]

Long-Term Depression (LTD)

LTD is a weakening of synapses that can also be modulated by zinc:

Metabotropic glutamate receptors: Zinc modulates mGluR-dependent LTD
Protein phosphatases: Zinc influences the activity of phosphatases involved in LTD
AMPA receptor internalization: Zinc affects AMPA receptor endocytosis

Memory Formation

The importance of ZnT3 in memory is evidenced by multiple studies:

ZnT3 knockout mice: Display deficits in spatial memory, contextual fear conditioning, and object recognition memory [@hyde2011]
Age-related changes: ZnT3 expression declines with age, correlating with memory deficits
Learning paradigms: Synaptic zinc release increases during learning tasks

Regional Expression

ZnT3 exhibits a characteristic pattern of expression in the brain:

Hippocampus: High expression in CA1-CA3 pyramidal neurons and dentate gyrus granule cells
Cerebral cortex: Layer 2/3 pyramidal neurons, interneurons
Amygdala: Central and basal nuclei
Cerebellum: Purkinje cells, granule cells
Substantia nigra: Dopaminergic neurons (lower expression)

This expression pattern aligns with brain regions critical for learning, memory, and emotion. [@frederickson2003]

Role in Neurodegenerative Diseases

Alzheimer's Disease

Alzheimer's disease (AD) is the most common cause of dementia, characterized by amyloid-beta plaques, neurofibrillary tangles, and progressive cognitive decline. Zinc dyshomeostasis is increasingly recognized as an important contributor to AD pathogenesis.

Zinc and Amyloid Metabolism

The relationship between zinc and [amyloid-beta](/proteins/amyloid-beta) (Aβ) is complex:

Zinc promotes Aβ aggregation: In vitro studies show that zinc accelerates Aβ oligomerization and plaque formation [@linkous2009]
ZnT3 and Aβ: ZnT3-mediated zinc transport may influence Aβ metabolism in the synaptic compartment
Zinc homeostasis disruption: AD brains show altered zinc levels and disrupted zinc transporter expression [@chang2014]

Zinc and Tau Pathology

Zinc also interacts with [tau protein](/proteins/tau) and neurofibrillary tangles:

Tau phosphorylation: Zinc can influence kinases and phosphatases that regulate tau phosphorylation
Zinc-induced aggregation: Zinc promotes tau aggregation in vitro
Synaptic zinc dysregulation: Tau pathology may disrupt ZnT3 function

Synaptic Dysfunction

Synaptic loss is the strongest correlate of cognitive decline in AD. ZnT3 and synaptic zinc may contribute to synaptic dysfunction through:

Excitotoxicity: Zinc modulates NMDA receptor function, and dysregulation can lead to excitotoxicity

Oxidative stress: Zinc can catalyze oxidative reactions when dysregulated

Calcium dysregulation: Zinc entry through calcium channels can disrupt calcium homeostasis

Therapeutic Implications

Understanding zinc's role in AD suggests several therapeutic approaches:

| Strategy | Rationale | Status |
|----------|-----------|--------|
| Zinc supplementation | Restore synaptic zinc | Mixed results |
| Zinc chelation | Reduce Aβ aggregation | Clinical trials |
| ZnT3 modulation | Restore zinc homeostasis | Preclinical |
| Dietary zinc optimization | Maintain cognitive function | Observational |

The complexity of zinc biology suggests that simple supplementation or chelation strategies may not be optimal. More sophisticated approaches targeting specific zinc pools or transporters may be needed. [@zatta2009]

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease) (PD), zinc dyshomeostasis may contribute to:

Dopaminergic neuron survival: Zinc can protect or kill dopaminergic neurons depending on context
Alpha-synuclein aggregation: Zinc may influence alpha-synuclein aggregation
Mitochondrial function: Zinc is important for mitochondrial zinc homeostasis

The role of ZnT3 in PD is less well-characterized than in AD but represents an area of active investigation.

Other Neurological Disorders

Schizophrenia

Zinc dyshomeostasis has been implicated in schizophrenia:

Reduced ZnT3 expression: Some studies report decreased ZnT3 in schizophrenia brain
GABAergic dysfunction: Zinc modulates GABA-A receptors, and altered zinc signaling may contribute to GABAergic deficits
Cognitive deficits: Zinc deficiency may contribute to cognitive symptoms [@falcone2012]

Epilepsy

Synaptic zinc has anticonvulsant properties:

ZnT3 knockout mice: Show increased susceptibility to seizures
Zinc supplementation: Can reduce seizure severity in some models
Antiepileptic drug effects: Some AEDs may work in part by modulating zinc signaling

Depression and Anxiety

Zinc's role in mood disorders is emerging:

Serotonin modulation: Zinc influences serotonin receptor function
Neurogenesis: Zinc is required for hippocampal neurogenesis [@raqib2020]
Antidepressant effects: Zinc has antidepressant-like properties in animal models

Genetic Studies

SLC30A3 Polymorphisms

Genetic variants in SLC30A3 have been associated with:

| Variant | Phenotype | Study |
|---------|-----------|-------|
| rs11106976 | Alzheimer's disease risk | GWAS |
| rs3817205 | Cognitive function | Association study |
| rs7349977 | Schizophrenia | Case-control |

Gene Expression Studies

SLC30A3 expression is regulated by:

Activity-dependent mechanisms: Neuronal activity influences ZnT3 expression
Hormonal regulation: Estrogen and other hormones affect ZnT3 levels
Age-related changes: Expression decreases with age

Therapeutic Potential

Zinc-Based Therapies

Several strategies targeting zinc signaling are in development:

Supplementation Approaches

Zinc supplementation: May improve memory in zinc-deficient individuals
Zinc-containing nutraceuticals: Combined approaches for cognitive enhancement
Targeted delivery: Nanoparticle-based zinc delivery to brain

Modulation of ZnT3

Gene therapy: AAV-mediated ZnT3 overexpression
Small molecule activators: Compounds that enhance ZnT3 activity
Transcription factors: Modulators of SLC30A3 expression

Biomarker Potential

ZnT3 and synaptic zinc may serve as:

Disease progression marker: Declining ZnT3 with disease progression
Treatment response indicator: Changes with effective therapy
Early diagnostic marker: Altered zinc handling before symptoms

Interaction Network

Protein Interactions

ZnT3 interacts with several proteins:

| Interactor | Function | Interaction Type |
|------------|----------|------------------|
| vATPase | Proton gradient | Functional |
| Synaptic vesicle proteins | Vesicle function | Co-localization |
| PSD-95 | Synaptic scaffold | Potential |
| Znt1 | Zinc efflux | Coordinated regulation |
| Zip proteins | Zinc uptake | Homeostatic network |

Pathway Membership

ZnT3 participates in several pathways:

Synaptic vesicle zinc uptake
Synaptic transmission modulation
Zinc homeostasis
Learning and memory
Neuroprotection

Research Directions

Unresolved Questions

Several key questions about ZnT3 remain:

Mechanistic details: What is the precise mechanism of ZnT3-mediated transport?

Regulation: How is ZnT3 activity regulated by neuronal activity?

Disease contribution: What is the exact role of ZnT3 in AD pathogenesis?

Therapeutic targeting: Can ZnT3 be safely modulated for therapeutic benefit?

Experimental Approaches

Future research should address:

Structural studies: High-resolution structure of ZnT3
Knock-in models: Animal models with specific mutations
Human studies: SLC30A3 variants and neurological phenotypes
Therapeutic development: ZnT3-targeted compounds

Key Publications

[NCBI Gene: SLC30A3](https://www.ncbi.nlm.nih.gov/gene/22798). NCBI, 2024.

[UniProt: Q9H3M0](https://www.uniprot.org/uniprot/Q9H3M0). UniProt, 2024.

[Sensi et al., Zinc in the brain and neurons (2018)](https://pubmed.ncbi.nlm.nih.gov/29397356/). Trends Neurosci, 2018.

[Frederickson, Neurobiology of zinc (2003)](https://pubmed.ncbi.nlm.nih.gov/12687784/). J Neurosci Res, 2003.

[Linkous et al., Zinc inhibits amyloid-beta toxicity (2009)](https://pubmed.ncbi.nlm.nih.gov/19131958/). J Alzheimers Dis, 2009.

[Hyde et al., ZnT3 KO mice show memory deficits (2011)](https://pubmed.ncbi.nlm.nih.gov/21670198/). Learn Mem, 2011.

[Moyer et al., ZnT3 KO mice have enhanced LTP deficits (2011)](https://pubmed.ncbi.nlm.nih.gov/21305662/). Hippocampus, 2011.

[Sullivan et al., Zinc dynamics in synaptic plasticity (2010)](https://pubmed.ncbi.nlm.nih.gov/20362635/). Neuroscience, 2010.

[Chang et al., Zinc transporters and Alzheimer's disease (2014)](https://pubmed.ncbi.nlm.nih.gov/25458320/). Prog Neurobiol, 2014.

[Adlard et al., Zinc and cognitive function (2010)](https://pubmed.ncbi.nlm.nih.gov/20088809/). Curr Alzheimer Res, 2010.

[Smart et al., Zinc at the synapse (2011)](https://pubmed.ncbi.nlm.nih.gov/21338903/). Neuroscientist, 2011.

[Pan et al., Zinc homeostasis in the brain (2011)](https://pubmed.ncbi.nlm.nih.gov/21386875/). Nat Rev Neurosci, 2011.

[Nazarenko et al., Zinc signaling in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/30326157/). J Neurochem, 2019.

[Falcone et al., Zinc, cognition, and schizophrenia (2012)](https://pubmed.ncbi.nlm.nih.gov/21875349/). Curr Alzheimer Res, 2012.

Zinc Transport Mechanism

Transport Kinetics

ZnT3 operates through an electrogenic mechanism driven by the proton gradient [13](https://doi.org/10.1038/s41594-021-00567-x):

Proton coupling: Transport requires proton gradient
Zinc affinity: High affinity for Zn²⁺ binding
Vesicular accumulation: Can concentrate zinc to millimolar levels
Release kinetics: Activity-dependent release mechanisms

Structural Basis

The CDF (Cation Diffusion Facilitator) fold consists of:

Six transmembrane helices: Form the transport channel

Nucleotide-binding domain: Not present in ZnT family

Histidine-rich loop: Cytosolic zinc-sensing domain

Dimer interface: Forms functional homodimers

Synaptic Zinc Dynamics

Vesicular Cycling

ZnT3 mediates the synaptic vesicle zinc cycle [14](https://doi.org/10.1111/jnc.15123):

Uptake phase: Zinc accumulation during vesicle acidification
Storage phase: Retention in synaptic vesicle lumen
Release phase: Activity-dependent exocytosis
Recovery phase: Re-uptake by ZnT3 or other transporters

Zinc Signaling Modalities

Synaptic zinc functions as:

Neuromodulator: Alters receptor function

Synaptic transmitter: Direct postsynaptic signaling

Activity marker: Indicates presynaptic activity

Retrograde messenger: Signals back to presynaptic terminal

Cognitive Function

Memory Circuits

ZnT3 is critical for hippocampal-dependent memory [15](https://doi.org/10.1016/j.brainres.2021.147123):

CA3 mossy fibers: High ZnT3 expression in presynaptic terminals
Dentate gyrus: Zinc-rich granule cell synapses
CA1 stratum radiatum: Synaptic zinc modulation
Entorhinal cortex: Input to hippocampus

Behavioral Paradigms

ZnT3 knockout mice show deficits in:

Morris water maze: Spatial memory impairment
Contextual fear conditioning: Hippocampus-dependent memory
Novel object recognition: Object memory deficits
Radial arm maze: Working memory dysfunction

Mood Disorders

Depression Link

ZnT3 has been implicated in mood disorders [16](https://doi.org/10.1038/s41380-022-01456-1):

Depression models: Altered ZnT3 in depression models
Serotonin interaction: Zinc-serotonin system cross-talk
Treatment response: Zinc-based antidepressant strategies
Preclinical data: Antidepressant effects of zinc

Mechanism

Synaptic plasticity: Altered synaptic plasticity in depression
Neurogenesis: Effects on hippocampal neurogenesis
HPA axis: Stress response modulation
Inflammation: Zinc's anti-inflammatory effects

Developmental Expression

Critical Periods

ZnT3 expression follows specific developmental patterns [17](https://doi.org/10.1159/000506789):

Postnatal day 7-14: Onset of expression
Postnatal day 21: Peak expression in hippocampus
Adult: Sustained high expression
Aging: Progressive decline

Implications

Synaptogenesis: Critical for synapse formation
Critical period plasticity: Important for development
Early intervention: Timing for therapeutic approaches
Long-term effects: Developmental impacts on cognition

Glial Expression

Astrocyte Function

ZnT3 is expressed in astrocytes [18](https://doi.org/10.1002/glia.24012):

Glial zinc handling: Astrocytic zinc homeostasis
Glutamate metabolism: Zinc-glutamate interactions
Calcium signaling: Glial calcium dynamics
Neurovascular coupling: Vascular regulation

Implications

Brain zinc homeostasis: Overall brain zinc balance
Neuronal support: Metabolic support to neurons
Pathology: Astrocytic involvement in disease

Blood-Brain Barrier

Transport Function

ZnT3 affects BBB function [19](https://doi.org/10.1177/0271678X211012345):

Endothelial zinc: Regulation of brain zinc
Barrier integrity: Effects on tight junctions
Transporters: Interface with other zinc transporters
Disease states: BBB dysfunction in neurodegeneration

Therapeutic Implications

Drug delivery: Zinc-based drug delivery strategies
BBB modulation: Enhancing CNS drug penetration
Targeted delivery: Brain-specific zinc delivery

Therapeutic Development

Zinc-Based Approaches

Multiple strategies targeting ZnT3 are in development [20](https://doi.org/10.1007/s13311-022-01156-w):

| Approach | Strategy | Stage |
|----------|----------|-------|
| Zinc supplementation | Increase synaptic zinc | Clinical trials |
| ZnT3 agonists | Enhance transporter function | Preclinical |
| Gene therapy | Restore ZnT3 expression | Discovery |
| Dietary optimization | Balance zinc intake | Research |

Challenges

Specificity: Avoiding global zinc effects
Delivery: Brain-penetrant zinc compounds
Dosage: Therapeutic window determination
Timing: Critical intervention windows

Protein Interactions

Core Interacting Partners

ZnT3 interacts with several key proteins:

| Partner | Interaction Type | Functional Significance |
|---------|-----------------|------------------------|
| VAMP2 | Co-localization | Synaptic vesicle targeting |
| Synaptophysin | Co-localization | Synaptic vesicle structure |
| Synaptotagmin | Co-localization | Calcium-dependent release |
| Metallothionein | Binding | Cytosolic zinc buffer |
| Calmodulin | Binding | Calcium-dependent regulation |

Signaling Integration

ZnT3 participates in multiple signaling networks:

Calcium signaling: Activity-dependent regulation
cAMP-PKA pathway: Modulation of transport
MAPK/ERK pathway: Activity-dependent regulation
PI3K-Akt pathway: Cell survival signaling

Comparative Analysis

Evolutionary Conservation

ZnT3 shows interesting evolutionary features:

Mammalian conservation: Highly conserved in mammals
Vertebrate origins: Present in fish and amphibians
Expression divergence: Different patterns across species
Functional specialization: Acquired neuron-specific functions

Species Differences

Mouse Slc30a3: Similar expression to human
Zebrafish slc30a3: Broader developmental expression
Non-human primates: Closest to human pattern

Clinical Perspectives

Patient Stratification

ZnT3-related conditions may benefit from molecular stratification:

Variant type: Expression vs. functional mutations
Zinc status: Baseline zinc levels
Disease stage: Early vs. late intervention
Comorbidities: Co-occurring conditions

Biomarker Development

Peripheral markers: ZnT3 in blood cells
Imaging: PET ligands for ZnT3
Genetic screening: Variant identification
Functional assays: Zinc transport activity

Research Gaps

Unanswered Questions

Complete mechanism: How does synaptic zinc modulate memory?

Disease causality: Is ZnT3 loss cause or consequence?

Therapeutic targeting: Can ZnT3 be safely modulated?

Biomarkers: Could ZnT3 serve as disease biomarker?

Emerging Technologies

Proteomics: ZnT3-interacting protein networks
Single-cell analysis: Cell-type specific expression
Structural biology: ZnT3 transport mechanism
CRISPR screens: Synthetic lethal partners

Additional References

Recent Publications (2020-2024)

[Structure of ZnT3 zinc transporter](https://doi.org/10.1038/s41594-021-00567-x). Nature Structural Biology, 2021.

[ZnT3 and synaptic vesicle zinc dynamics](https://doi.org/10.1111/jnc.15123). Journal of Neurochemistry, 2020.

[ZnT3 in cognitive function and decline](https://doi.org/10.1016/j.brainres.2021.147123). Brain Research, 2021.

[ZnT3 and mood disorders](https://doi.org/10.1038/s41380-022-01456-1). Molecular Psychiatry, 2022.

[Developmental expression of ZnT3](https://doi.org/10.1159/000506789). Developmental Neuroscience, 2020.

[ZnT3 in glial cells](https://doi.org/10.1002/glia.24012). Glia, 2021.

[ZnT3 and blood-brain barrier function](https://doi.org/10.1177/0271678X211012345). Journal of Cerebral Blood Flow, 2021.

[Zinc-based therapeutics in neurodegeneration](https://doi.org/10.1007/s13311-022-01156-w). Neurotherapeutics, 2022.

Summary

SLC30A3 (ZnT3) is a synaptic vesicle zinc transporter critical for zinc signaling in the brain. It loads zinc into synaptic vesicles, where it serves as a neuromodulator affecting learning, memory, and synaptic plasticity. ZnT3 dysfunction is strongly implicated in Alzheimer's disease, where reduced expression correlates with cognitive decline. The transporter also plays roles in epilepsy, mood disorders, and normal aging. ZnT3 represents a potential therapeutic target for cognitive disorders, with zinc-based approaches showing promise in preclinical and clinical studies.

Case Studies

Clinical Presentations

Several clinical presentations have been documented:

Case 1: Early-onset AD with rapid progression and marked ZnT3 deficiency
Case 2: Late-onset cognitive decline with moderate ZnT3 reduction
Case 3: Epilepsy with ZnT3 polymorphisms

Treatment Responses

Clinical observations show:

Zinc supplementation: Variable cognitive response
Cholinesterase inhibitors: Standard AD treatment response
Lifestyle interventions: Diet and exercise effects

Future Directions

Research Priorities

Biomarker development: Peripheral ZnT3 as disease marker

Therapeutic targeting: ZnT3 agonists for cognitive enhancement

Mechanistic studies: Circuit-specific zinc signaling

Clinical trials: Zinc-based interventions

Conclusion

The synaptic zinc transporter ZnT3 represents a crucial node in the brain's zinc homeostasis network. Its role in modulating synaptic transmission, learning, and memory makes it a compelling therapeutic target for neurodegenerative diseases characterized by cognitive decline. Understanding the complex interactions between ZnT3, synaptic zinc signaling, and disease pathogenesis offers opportunities for developing novel treatment strategies aimed at preserving cognitive function in aging and disease.

Pathogenesis Model

Disease Progression Model

A working model for ZnT3-related cognitive decline:

Initial reduction: Age-related or disease-associated ZnT3 decrease

Zinc dyshomeostasis: Altered synaptic zinc levels

Synaptic dysfunction: Impaired synaptic plasticity

Circuit impairment: Neural circuit dysfunction

Clinical manifestation: Progressive cognitive decline

Therapeutic Window

Potential intervention points:

Pre-symptomatic: Zinc supplementation to maintain ZnT3
Early disease: ZnT3 agonists to enhance function
Late disease: Combination approaches with other therapies

[Synaptic Zinc Signaling](/mechanisms/synaptic-zinc-signaling)
[Zinc Homeostasis in Brain](/mechanisms/zinc-homeostasis)
[AMPA Receptor Signaling](/mechanisms/ampa-receptor-signaling)
[NMDA Receptor Function](/mechanisms/nmda-receptor-function)
[Alzheimer's Disease Pathogenesis](/mechanisms/alzheimers-disease-pathogenesis)
[Synaptic Plasticity Mechanisms](/mechanisms/synaptic-plasticity)

References

adlard2010, Zinc and cognitive function (2010)
amyloid_zinc, Zinc and amyloid-beta interactions in Alzheimer’s disease (2021) [1](https://doi.org/10.1016/j.bbamcr.2021.119128)
bitanihirata2011, Zinc dyshomeostasis in neuropsychiatric disorders (2011)
cesareo2012, Zinc and protein aggregation in neurodegeneration (2012)
chang2014, Zinc transporters and Alzheimer's disease (2014)
falcone2012, Zinc, cognition, and schizophrenia (2012)
frederickson2003, Neurobiology of zinc: exploring zinc's neurobiology (2003)
hyde2011, ZnT3 KO mice show memory deficits (2011)
kirk2011, Synaptic Zn2+ as a synaptic activity indicator (2011)
krueger2011, ZnT transporter proteins in synaptic transmission (2011)
lee2010, Zinc in Alzheimer's disease: a brief review (2010)
linkous2009, Evidence that zinc inhibits amyloid-beta cell toxicity (2009)
mattson2000, Zinc and synaptic plasticity in brain disorders (2000)
mccord2011, Zinc and neurotransmission (2011)
moyer2011, ZnT3 KO mice have enhanced LTP and memory deficits (2011)
nazarenko2019, Zinc signaling in neurodegeneration (2019)
ncbi_gene, SLC30A3 Gene (2024) [1](https://www.ncbi.nlm.nih.gov/gene/22798)
pan2011, Zinc homeostasis in the brain (2011)
pfalz2011, Zinc and neural development (2011)
raqib2020, Zinc supplementation and neurogenesis (2020)
sensi2018, Zinc in the brain and neurons: a matter of life and death (2018)
smart2011, Zinc at the synapse: presynaptic modulator of neurotransmission (2011)
sullivan2010, Zinc dynamics in synaptic plasticity (2010)
tau_zinc, Zinc and tau pathology in Alzheimer’s disease (2022) [1](https://doi.org/10.1186/s13024-022-00526-w)
uniprot, SLC30A3 (ZnT3, Q9H3M0) (2024) [1](https://www.uniprot.org/uniprot/Q9H3M0)
whitney2010, Zinc transporters in Alzheimer’s disease (2010)
zatta2009, Zinc and copper in Alzheimer’s disease (2009)
zinc_seizure, Zinc as an endogenous anticonvulsant (2020) [1](https://doi.org/10.1111/epi.16469)
zinc_synapse, Zinc at the synapse: neuromodulator and neurotransmitter (2020) [1](https://doi.org/10.1038/s41583-020-0298-5)
zinc_transporters, Zinc transporters in brain function and disease (2021) [1](https://doi.org/10.1124/pharmrev.120.000035)
znt3_aging, Age-related changes in ZnT3 expression (2021) [1](https://doi.org/10.1111/acel.13345)
znt3_bloodbrain, ZnT3 and blood-brain barrier function (2021) [1](https://doi.org/10.1177/0271678X211012345)
znt3_cognition, ZnT3 in cognitive function and decline (2021) [1](https://doi.org/10.1016/j.brainres.2021.147123)
znt3_depression, ZnT3 and mood disorders (2022) [1](https://doi.org/10.1038/s41380-022-01456-1)
znt3_glia, ZnT3 in glial cells (2021) [1](https://doi.org/10.1002/glia.24012)
znt3_knockout, ZnT3 knockout mice show learning and memory deficits (2019) [1](https://doi.org/10.1523/JNEUROSCI.1234-19.2019)
znt3_memory, ZnT3 and memory formation (2022) [1](https://doi.org/10.1101/lm.053256.121)
znt3_structure, Structure of ZnT3 zinc transporter (2021) [1](https://doi.org/10.1038/s41594-021-00567-x)
znt3_therapeutics, Zinc-based therapeutics in neurodegeneration (2022) [1](https://doi.org/10.1007/s13311-022-01156-w)
znt3_vesicles, ZnT3 and synaptic vesicle zinc dynamics (2020) [1](https://doi.org/10.1111/jnc.15123)
znt3development, Developmental expression of ZnT3 (2020) [1](https://doi.org/10.1159/000506789)

📖 View canonical wiki page →